UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 389

Sortiert nach

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy

American journal of respiratory and critical care medicine, 2006-10, Vol.174 (8), p.935-952

2006

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru

Emerging infectious diseases, 2003-12, Vol.9 (12), p.1571-1578

2003

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis elimination in the United States: an achievable goal or an illusion?

American journal of respiratory and critical care medicine, 2012-08, Vol.186 (3), p.i-iii

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

JAMA : the journal of the American Medical Association, 1999-03, Vol.281 (11), p.1014

1999

Link zum Volltext

Verfügbarkeit prüfen

Use of Rapid Genomic Deletion Typing To Monitor a Tuberculosis Outbreak within an Urban Homeless Population

Journal of Clinical Microbiology, 2005-11, Vol.43 (11), p.5550-5554

2005

Link zum Volltext

Verfügbarkeit prüfen

Field assessment of a model tuberculosis outbreak response plan for low-incidence areas

BMC public health, 2007-10, Vol.7 (1), p.307-307, Article 307

2007

Link zum Volltext

Verfügbarkeit prüfen

Expanded Geographical Distribution of the N Family of Mycobacterium tuberculosis Strains within the United States

Journal of Clinical Microbiology, 2004-03, Vol.42 (3), p.1064-1068

2004

Link zum Volltext

Verfügbarkeit prüfen

Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America

MMWR. Recommendations and reports, 2005-11, Vol.54 (12), p.1-81

2005

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Nosocomial Multidrug-Resistant Tuberculosis—Global Spread of the Third Epidemic

The Journal of infectious diseases, 1997-09, Vol.176 (3), p.748-751

Nolan, Charles M.

1997

Link zum Volltext

Verfügbarkeit prüfen

Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime

American journal of respiratory and critical care medicine, 2003-08, Vol.168 (4), p.412-413

Nolan, Charles M

2003

Link zum Volltext

Verfügbarkeit prüfen

Community-Wide Implementation of Targeted Testing for and Treatment of Latent Tuberculosis Infection

Clinical infectious diseases, 1999-10, Vol.29 (4), p.880-887

NOLAN, C. M

1999

Link zum Volltext

Verfügbarkeit prüfen

American thoracic society/centers for disease control and prevention/infectious diseases society of America : Controlling tuberculosis in the United States

American journal of respiratory and critical care medicine, 2005-11, Vol.172 (9), p.1169-1227

2005

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for pediatric tuberculosis infection and disease after household exposure to adult index cases in Alaska

The Journal of pediatrics, 1998-03, Vol.132 (3), p.509-513

1998

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington

American journal of respiratory and critical care medicine, 1997-08, Vol.156 (2), p.573-577

1997

Link zum Volltext

Verfügbarkeit prüfen

Hepatotoxicity Associated With Acetaminophen Usage in Patients Receiving Multiple Drug Therapy for Tuberculosis

Chest, 1994-02, Vol.105 (2), p.408-411

1994

Link zum Volltext

Verfügbarkeit prüfen

Migrating populations--a closer view of who, why, and so what

Emerging infectious diseases, 2001-01, Vol.7 (3 Suppl), p.551-551

2001

Link zum Volltext

Verfügbarkeit prüfen

Beyond Directly Observed Therapy for Tuberculosis

Chest, 1997-05, Vol.111 (5), p.1151-1153

Nolan, Charles M.

1997

Link zum Volltext

Verfügbarkeit prüfen

Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards

American journal of respiratory and critical care medicine, 2000-04, Vol.161 (4), p.1167-1171

2000

Link zum Volltext

Verfügbarkeit prüfen

Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis

American journal of respiratory and critical care medicine, 1999-08, Vol.160 (2), p.508-512

1999

Link zum Volltext

Verfügbarkeit prüfen

Failure to Mention Fixed-Dose Drug Combinations in the ATS/CDC/IDSA Tuberculosis Control Statement/From the Authors

American journal of respiratory and critical care medicine, 2006-03, Vol.173 (6), p.684

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Bacterial Meningitis with Intravenous Amoxicillin

Antimicrobial Agents and Chemotherapy, 1979-08, Vol.16 (2), p.171-175

1979

Link zum Volltext

Verfügbarkeit prüfen

Failure to Mention Fixed-Dose Drug Combinations in the ATS/CDC/IDSA Tuberculosis Control Statement

American journal of respiratory and critical care medicine, 2006-03, Vol.173 (6), p.684-685

2006

Link zum Volltext

Verfügbarkeit prüfen

Cefotaxime Treatment of Pelvic Inflammatory Disease

Antimicrobial Agents and Chemotherapy, 1981-12, Vol.20 (6), p.847-849

1981

Link zum Volltext

Verfügbarkeit prüfen

Antituberculosis Drugs and Hepatotoxicity

American journal of respiratory and critical care medicine, 2007-04, Vol.175 (8), p.858-859

2007

Link zum Volltext

Verfügbarkeit prüfen

Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months

The international journal of tuberculosis and lung disease, 2002-11, Vol.6 (11), p.952

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(340)

Publikationsform

Sprache

Englisch
(386)
Japanisch
(34)
Serbian
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy

Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru

Tuberculosis elimination in the United States: an achievable goal or an illusion?

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

Use of Rapid Genomic Deletion Typing To Monitor a Tuberculosis Outbreak within an Urban Homeless Population

Field assessment of a model tuberculosis outbreak response plan for low-incidence areas

Expanded Geographical Distribution of the N Family of Mycobacterium tuberculosis Strains within the United States

Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America

Editorial: Nosocomial Multidrug-Resistant Tuberculosis—Global Spread of the Third Epidemic

Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime

Community-Wide Implementation of Targeted Testing for and Treatment of Latent Tuberculosis Infection

American thoracic society/centers for disease control and prevention/infectious diseases society of America : Controlling tuberculosis in the United States

Risk factors for pediatric tuberculosis infection and disease after household exposure to adult index cases in Alaska

Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington

Hepatotoxicity Associated With Acetaminophen Usage in Patients Receiving Multiple Drug Therapy for Tuberculosis

Migrating populations--a closer view of who, why, and so what

Beyond Directly Observed Therapy for Tuberculosis

Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards

Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis

Failure to Mention Fixed-Dose Drug Combinations in the ATS/CDC/IDSA Tuberculosis Control Statement/From the Authors

Treatment of Bacterial Meningitis with Intravenous Amoxicillin

Failure to Mention Fixed-Dose Drug Combinations in the ATS/CDC/IDSA Tuberculosis Control Statement

Cefotaxime Treatment of Pelvic Inflammatory Disease

Antituberculosis Drugs and Hepatotoxicity

Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months

Suchergebnisse filtern